middle.news
Mayne Pharma Rebukes Cosette’s Claim, Secures FDA Clearance Amid Scheme Tensions
9:30am on Wednesday 4th of June, 2025 AEST
•
Healthcare
Read Story
Mayne Pharma Rebukes Cosette’s Claim, Secures FDA Clearance Amid Scheme Tensions
9:30am on Wednesday 4th of June, 2025 AEST
Key Points
Cosette alleges material adverse change; Mayne Pharma denies
No termination notice received despite consultation period expiry
FDA issues close-out letter resolving prior regulatory issues
Mayne Pharma reserves rights including potential litigation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE